MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced the successful closing of its public offering of 30,434,783 shares of common stock on Friday. Each share was sold at $1.15, generating gross proceeds of approximately $35 million before deducting expenses.
The company plans to use the net proceeds for general corporate purposes, capital expenditures, working capital, and administrative expenses. A premier mutual fund and leading life sciences investors participated in the offering.
Titan Partners Group, a division of American Capital Partners, acted as the sole book-running manager.
The offering was made under a shelf registration statement on Form S-3, which was filed with the Securities and Exchange Commission (SEC) on April 18, 2024, and became effective on May 1, 2024. A final prospectus supplement and accompanying base prospectus were filed with the SEC.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.